Iterum Therapeutics

PharmaceuticalsSeries BDublin, Irelanditerumtx.com

Latest round

Series B

Last raised

May 2017

Total raised

$105M

Investors

9

About Iterum Therapeutics

Founded in 2015 in Dublin, Ireland, Iterum Therapeutics plc specializes in anti-infective therapies.00 mn to date.Iterum Therapeutics plc specializes in developing innovative anti-infective therapies, particularly focusing on the novel antibiotic sulopenem, designed for both oral and intravenous use.34 mn.S. and international markets.

Who invested in Iterum Therapeutics

9 investors across 2 rounds

See all investors in Iterum Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    May 19, 2017

    Amount

    $65M

    Investors

    Locked

  2. Series A

    Mar 24, 2016

    Amount

    $40M

    Investors

    Locked

Questions about Iterum Therapeutics

Who invested in Iterum Therapeutics?

Iterum Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Iterum Therapeutics raised?

Iterum Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Iterum Therapeutics last raise money?

Iterum Therapeutics's most recent round on record is a Series B, in May 2017.

What does Iterum Therapeutics do?

Founded in 2015 in Dublin, Ireland, Iterum Therapeutics plc specializes in anti-infective therapies.

Where is Iterum Therapeutics headquartered?

Iterum Therapeutics is headquartered in Dublin, Ireland.

Which VCs invest in companies like Iterum Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Iterum Therapeutics's stage. Their profiles are linked below.

Raising like Iterum Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.